Sign inJoin waitlistJoin the waitlist

Ana Xavier

Physician · UAB Heersink School of Medicine

Credentials: · · · · · ·

History

UAB Heersink School of Medicine
2019–Present

Pediatric Hematology/Oncology
Children's Hospital of Michigan
2007–2009
Pediatrics
Medical University of South Carolina College of Medicine
1998–2001
University of São Paulo
1994–1998

Research

KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer
Clinical Cancer Research · 2007 · 524 citations
Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with…
Journal of Clinical Oncology · 2005 · 494 citations
Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib
Annals of Oncology · 2007 · 232 citations

Luciano Costa
19 papers
Jeffrey Taub
10 papers
Narendranath Epperla
8 papers
Jonathon Cohen
5 papers
Julio Chavez
5 papers
Mitchell Cairo
5 papers
Nishitha Reddy
5 papers
Aditi Dhir
4 papers · 1 as a fellow
Francisco Hernandez-Ilizaliturri
4 papers
Frederick Lansigan
4 papers
MG
Martha Glenn
4 papers
Reem Karmali
4 papers

Clinical trials

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2023–2031